TAG:
commercial laboratory
How Local Path Groups Can Keep Patient Access
By Robert Michel | From the Volume XI No.13 – September 20, 2004 Issue
CEO SUMMARY: For pathology groups operating their own histology and cytology labs, a growing problem is access to patients covered by exclusive managed care contracts. In the Northeast, several persistent pathology group practices are using some effective business strategies to fight this…
Lab Contracting Fracas In British Columbia
By Robert Michel | From the Volume XI No. 6 – April 26, 2004 Issue
CEO SUMMARY: Government healthcare officials in British Columbia are taking definitive steps to recast the existing status quo between private commercial laboratory companies and public (government) hospital laboratories in the province. Although the stated goals are to reduce the cost of…
Specialty Laboratories, Cytyc, Quest Diagnostics, DakoCytomation, Abbot
By Robert Michel | From the Volume XI No. 6 – April 26, 2004 Issue
SPECIALTY LABORATORIES SHOWS VOLUME GROWTH DURING CALENDAR 2003 If the financial performance of Specialty Laboratories, Inc. in fourth quarter 2003 is an accurate measure, it appears the company has moved past its troubling problems of 2002. For fourth quarter 2003, Special…
Arguing in Favor of Regional Laboratory Networks
By R. Lewis Dark | From the Volume XI No. 5 – April 5, 2004 Issue
TWO STORIES IN THIS ISSUE OF THE DARK REPORT DEMONSTRATE why regional laboratory networks are a business model which should be revisited by hospital laboratories with outreach programs. Seattle provides a great example of how an existing laboratory network gives hospitals in that region an addition…
Seattle Hospital Lab JVs Involve Quest & LabCorp
By Robert Michel | From the Volume XI No. 5 – April 5, 2004 Issue
CEO SUMMARY: Joint ventures and collaborative business relationships between hospital laboratories and commercial laboratories continue to be a difficult business model. Recent events in Seattle demonstrate the challenges and frustrations of establishing such ventures, then making them su…
LabOne in Cincinnati: Watch Events Unfold
By Robert Michel | From the Volume XI No. 3 – February 23, 2004 Issue
CEO SUMMARY: It’s another example of a commercial laboratory taking over the laboratory assets of a multi-hospital consolidated laboratory. Will LabOne manage these assets and get more growth, more cost savings, and more profit? If this happens, it will mark the third time in r…
Diversifying Lab Management’s “Gene Pool” of Methods
By R. Lewis Dark | From the Volume XI No. 3 – February 23, 2004 Issue
I ENCOURAGE OUR CLIENTS AND REGULAR READERS to give careful thought to the intelligence findings provided by our editor about the unfolding laboratory joint venture in Cincinnati between LabOne, Inc. and The Health Alliance. (See …
Web Lab Test Ordering Market Is Increasing
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: In recent years, the market for browser-based laboratory test ordering and results reporting systems has grown at a steady rate. Second and third generation products are more robust, offer more features, and are easier to install and operate. To date, smaller start-up compani…
More Firms Now Offer Web Lab Info Products
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: Since our last vendor directory in winter 2001, the number of companies selling browser-based systems for laboratory testing ordering and results reporting has doubled! That’s a sign that laboratories recognize the need to have an Internet strategy and are taking steps to d…
“January 12, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 1 – January 12, 2004 Issue
There’s a new joint venture between a commercial laboratory and a multi-hospital group. On January 5, 2004, LabOne, Inc. of Lenexa, Kansas announced that it had completed negotiations with The Health Alliance of Greater Cincinnati. LabOne paid $38.5 millio…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized